The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Continuous Renal Replacement Therapy Market Progress Between 2026 And 2030?
The continuous renal replacement therapy market size has experienced significant expansion in recent years. It is projected to grow from $1.73 billion in 2025 to $1.92 billion in 2026, at a compound annual growth rate (CAGR) of 10.8%. This growth observed historically can be attributed to factors such as a rising incidence of acute kidney injury in critical care, an increase in ICU admissions due to sepsis and multi-organ failure, the growing adoption of renal support therapies, the expansion of critical care infrastructure, and enhanced survival rates for critically ill patients.
The continuous renal replacement therapy market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Several factors are expected to drive this growth during the forecast period, including an aging demographic prone to acute kidney injury (AKI), the escalating prevalence of critical illnesses, the increasing integration of sophisticated renal support technologies, a heightened emphasis on personalized critical care approaches, and the expansion of intensive care infrastructure in developing economies. Key trends projected for this period involve the increasing utilization of CRRT within intensive care units, a growing application of continuous treatment modalities for patients with unstable hemodynamics, an escalating need for precise fluid and electrolyte regulation, the extended application of CRRT in pediatric and neonatal settings, and a rising inclination towards integrated CRRT systems and their associated consumables.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp
Which Primary Drivers Are Impacting The Continuous Renal Replacement Therapy Market Growth?
The continuous renal replacement therapy market is expected to see growth, driven by the increasing occurrence of chronic kidney diseases moving forward. Chronic kidney disease (CKD) is a persistent medical state characterized by the gradual deterioration of kidney function over time, resulting in diminished filtration of waste substances from the bloodstream. Factors contributing to the growing prevalence of chronic kidney diseases include evolving lifestyles, an aging demographic, and heightened rates of diabetes and hypertension. Continuous renal replacement therapy finds use in chronic kidney disease cases, specifically during acute flare-ups or related complications, to help regulate fluid balance and consistently eliminate metabolic waste products. For example, in May 2024, data from the Centers for Disease Control and Prevention, a U.S.-based national public health agency, estimated that more than 1 in 7 adults in the US, which translates to over 35.5 million people, suffer from chronic kidney disease (CKD). Significantly, close to 90% of these individuals are unaware of their illness, highlighting a considerable shortfall in early detection and public awareness initiatives for CKD in the US. Consequently, the expanding occurrence of chronic kidney diseases is a key factor propelling the growth of the continuous renal replacement therapy market.
What Are The Different Segment Types In The Continuous Renal Replacement Therapy Market Segment Breakdown?
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care
Subsegments:
1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets
2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets
Which Trends Are Shaping Growth In The Continuous Renal Replacement Therapy Market?
Major companies operating in the continuous renal replacement therapy market are focusing on developing innovative renal therapy choices for dialysis patients to improve treatment effectiveness, enhance patient outcomes, and reduce complications associated with traditional dialysis methods. This advanced therapy runs continuously, typically over 24 hours, and is less harsh on the body compared to standard dialysis, making it appropriate for patients with acute kidney injuries or severe health conditions. For instance, in January 2023, based on a report published by Peconic Bay Medical Center (PBMC), a US-based medical center that provides medical services, including emergency care and surgical services, introduced a new renal therapy option for dialysis patients. The therapy is crafted to be more comfortable for patients who might not tolerate standard dialysis due to their medical conditions. CRRT is administered at a slower rate than traditional dialysis, which aids in minimizing stress on critically ill patients.
Who Are The Well-Known Companies In The Continuous Renal Replacement Therapy Market?
Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Toray Medical Co. Ltd., Kawasumi Hemofiltration Inc.
Get The Full Continuous Renal Replacement Therapy Market Report:
Which Region Is The Largest In The Continuous Renal Replacement Therapy Market?
North America was the largest region in the continuous renal replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Continuous Renal Replacement Therapy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=15777&type=smp
Browse Through More Reports Similar to the Global Continuous Renal Replacement Therapy Market 2026, By The Business Research Company
Respiratory Inhaler Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Air Pressure Sensors Market Report 2026
https://www.thebusinessresearchcompany.com/report/air-pressure-sensors-global-market-report
Respiratory Oxygen Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model